Table 1.
Immunological status.
| Normal range | ||
|---|---|---|
| WBC | 7.05×109/l | 4.4–11.6×109/l |
| neu | 58% | 34–69% |
| ly | 31% | 19–52% |
| mo | 8% | 5–15 |
| eo | 3% | 0–9% |
| IgG | 0.2 g/l | 6.3–15.8 g/l |
| IgG1 | <0.19 g/l | 3.69–11.1 g/l |
| IgG2 | <0.36 g/l | 0.75–3.95 g/l |
| IgA | 0.01 g/l | 0.4–2.51 g/l |
| IgM | 2.16 g/l | 0.47.2.75 g/l |
| Total IgE | 11.6 kU/l | <76.4 kU/l |
| CD3 | 69% (1078/μl) | 54–80% (1320–3300/μl) |
| CD3+CD4+ | 34% (531/μl) | 25–46% (620–2400/μl) |
| CD3+CD8 | 30% (469/μl) | 15–42% (390–1100/μl) |
| CD19 | 15% (234/μl) | 9–37% (270–2050/μl) |
| CD3-CD16+56+ | 17% (266/μl) | 5–20% (190–740/μl) |
| CD3-CD16+56+ | 17% (266/μl) | 5–20% (190–740/μl) |
| Antitetanus antibody by ELISA | 1 IU/ml | 0.01–0.15 IU/ml |
| Isohaemagglutinins | B Rh +, anti-A IgM 64 (score 59), anti-A IgG 32 (score 51) | Anti-A Ig M ≥1:8 |
| T-lymphocyte proliferation test | Mitogens: | |
| PHA 8.3% S phase | 17–39% | |
| Con A 3.1% S phase | 7–18% | |
| PWM 10.3% S phase | 9–25% |
CD – cluster of differentiation; Con A – concanavalin A; ELISA – enzyme-linked immunosorbent assay; eo – eosinophyls; Ig – immunoglobulin; PHA – phytohemagglutinin; ly – lymphocytes; mo – monocytes; neu – neutrophils; PWM – pokeweed; Rh – rhesus; WBC – white blood cells.